Study on the components and mechanism of Yimaikang Soft Capsules in treating ischemic cardio-cerebrovascular diseases based on HPLC-Q-Exactive Orbitrap MS and network pharmacology
1Modern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan 030006, China
2Key Laboratory of Chemical Biology and Molecular Engineering of the Ministry of Education, Shanxi University, Taiyuan 030006, China
3Beijing Huanghe Yishengtang Traditional Chinese Medicine Limited Liability Company, Beijing 102600, China
收起